Cagrilintide is a synthetic long-acting analog of the naturally occurring hormone amylin. Laboratory research involving Cagrilintide explores its potential effects on appetite regulation, energy balance, and weight management. Studies suggest that Cagrilintide may modulate satiety signals and gastrointestinal motility, influencing food intake and energy consumption pathways.
Scientific investigations are actively examining Cagrilintide’s potential impacts on metabolic processes, particularly related to obesity, appetite control, and energy homeostasis in laboratory settings.
Important Notice: This product is intended strictly for research purposes only. It is not approved by the FDA and is not intended for human or animal consumption, nor for diagnostic, therapeutic, or clinical applications. Usage of Cagrilintide outside laboratory research settings violates sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. §§ 355(a) and 331(d).
Product Specifications:
- Purity: ≥99% (HPLC verified)
- Formulation: Lyophilized powder
- Molecular Formula: C171H267N51O53
- Molecular Weight: 3955.3 g/mol
- CAS Number: 1222316-42-2
Source: PubChem